Suppliers / Industrial Farmacéutica Cantabria

Industrial Farmacéutica Cantabria

Spain 5 employees Updated 9 July 2026

Industrial Farmacéutica Cantabria is a finished-dose manufacturer based in Spain. It appears in 197 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), AEMPS (ES) and EMA. Its GMP standing is certified by AEMPS (ES), US FDA and EAEU_EEC, among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 17 May 2024 as VAI.

0
active US DMFs
0
valid CEPs
7
registered plants 2 with an FDA FEI number
197
filings across 9 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 17 May 2024 VAI US FDA
  • 6 September 2023 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Santander, United Arab Emirates Not on file
Madrid, Spain Not on file
Cantabria, Spain Not on file
SANTANDER, Spain Not on file
Torrejon De Ardoz, Spain Not on file
Spain, Spain 3005887891

1 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
DIGEMAPS (DO) 103 None
AEMPS (ES) 56 3
EMA 29 1
NPRA (MY) 3 None
EDE (AE) 2 None
MPA (SE) 1 None
US FDA None 2
EAEU_EEC None 1
ANVISA (Brazil) None 1

Questions about Industrial Farmacéutica Cantabria

Does Industrial Farmacéutica Cantabria hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Industrial Farmacéutica Cantabria. It does have 197 filings with 9 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Industrial Farmacéutica Cantabria FDA-registered?
2 sites operated by Industrial Farmacéutica Cantabria carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Industrial Farmacéutica Cantabria's last inspection go?
The most recent inspection on record closed on 17 May 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 2 inspections are on file.
Where does Industrial Farmacéutica Cantabria manufacture?
7 registered sites are on record, in United Arab Emirates and Spain (Santander, Madrid and Cantabria among others). Every site is listed on this page with the register it came from.
Which regulators recognise Industrial Farmacéutica Cantabria's GMP?
Current GMP certificates are on record from AEMPS (ES), US FDA, EEC (Eurasian Economic Union), ANVISA (Brazil) and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Industrial Farmacéutica Cantabria comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 17 May 2024.

Comparable suppliers

Alcaliber S A also in Spain Altan Pharmaceuticals also in Spain Berlimed also in Spain Casen Recordati, S.L also in Spain Cyndea Pharma, S.L also in Spain

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates